Literature DB >> 17295100

Oral candidiasis and oral yeast carriage among institutionalised South African paediatric HIV/AIDS patients.

Elaine Blignaut1.   

Abstract

South Africa currently has an estimated 500,000 AIDS orphans, many of whom are HIV-positive. Oral candidiasis commonly occurs in both adult and paediatric HIV/AIDS patients. Published information on HIV-positive children in Africa mainly concerns hospitalised patients. The objective of this study was to determine the prevalence of oral candidiasis and oral yeast carriage among paediatric HIV/AIDS patients residing in orphanages in Gauteng, South Africa, and to compare the prevalence of isolated yeast species with species obtained from adult HIV/AIDS patients. Eighty-seven paediatric HIV/AIDS patients residing in five homes were examined and a swab taken from the dorsal surface of the tongue, cultured on CHROMagar and yeast isolates identified with the ATB 32C commercial system. The species prevalence of 57 identified isolates was compared with that of 330 isolates from adult HIV/AIDS patients. Twelve (13.8%) children presented with clinically detectable candidiasis. Yeasts were isolated from 0% to 53% of children in the individual homes, with Candida albicans (40.4%) and C. dubliniensis (26.3%) constituting the most frequently isolated species. Gentian violet prophylaxis was administered in one particular home and a higher carriage rate (66.6%) of non-C. albicans and non-C. dubliniensis was observed among these children. The prevalence of C. albicans was lower while the prevalence of C. dubliniensis, C. glabrata and C. tropicalis was significantly higher (p < or = 0.001) among the children than among adult HIV/AIDS patients. These findings indicate a role for yeast culture and species determination in cases with candidiasis in institutionalized paediatric HIV/AIDS patients.

Entities:  

Mesh:

Year:  2007        PMID: 17295100     DOI: 10.1007/s11046-006-0087-9

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  48 in total

Review 1.  The epidemiology of the oral lesions of HIV infection in the developed world.

Authors:  J S Greenspan; D Greenspan
Journal:  Oral Dis       Date:  2002       Impact factor: 3.511

2.  Oral candidal populations in health and disease.

Authors:  T M Arendorf; D M Walker
Journal:  Br Dent J       Date:  1979-11-20       Impact factor: 1.626

3.  Caries experience and cariogenic markers in HIV-positive children and their siblings.

Authors:  A Madigan; P A Murray; M Houpt; F Catalanotto; M Feuerman
Journal:  Pediatr Dent       Date:  1996 Mar-Apr       Impact factor: 1.874

4.  Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States.

Authors:  T F Meiller; M A Jabra-Rizk; A a Baqui; J I Kelley; V I Meeks; W G Merz; W A Falkler
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1999-11

5.  Frequency, intensity, species, and strains of oral Candida vary as a function of host age.

Authors:  C L Kleinegger; S R Lockhart; K Vargas; D R Soll
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

Review 6.  Candida dubliniensis: an emerging opportunistic pathogen.

Authors:  D Sullivan; D Coleman
Journal:  Curr Top Med Mycol       Date:  1997-12

Review 7.  Description and epidemiology of nursing caries.

Authors:  A R Milnes
Journal:  J Public Health Dent       Date:  1996       Impact factor: 1.821

8.  Oral lesions and dental caries status in perinatally HIV-infected children in Northern Thailand.

Authors:  S Pongsiriwet; A Iamaroon; S Kanjanavanit; K Pattanaporn; S Krisanaprakornkit
Journal:  Int J Paediatr Dent       Date:  2003-05       Impact factor: 3.455

Review 9.  Response to Weinstein: public health issues in early childhood caries.

Authors:  A M Horowitz
Journal:  Community Dent Oral Epidemiol       Date:  1998       Impact factor: 3.383

10.  Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group.

Authors:  P M Flynn; C K Cunningham; T Kerkering; A R San Jorge; V B Peters; P A Pitel; J Harris; G Gilbert; L Castagnaro; P Robinson
Journal:  J Pediatr       Date:  1995-08       Impact factor: 4.406

View more
  12 in total

1.  Increased risk of mortality and loss to follow-up among HIV-positive patients with oropharyngeal candidiasis and malnutrition before antiretroviral therapy initiation: a retrospective analysis from a large urban cohort in Johannesburg, South Africa.

Authors:  Denise Evans; Mhairi Maskew; Ian Sanne
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-03

2.  Comparison of antifungal activities of gentian violet and povidone-iodine against clinical isolates of Candida species and other yeasts: a framework to establish topical disinfectant activities.

Authors:  Shigemi Kondo; Yoko Tabe; Toshihiko Yamada; Shigeki Misawa; Toyoko Oguri; Akimichi Ohsaka; Takashi Miida
Journal:  Mycopathologia       Date:  2011-08-12       Impact factor: 2.574

3.  Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals.

Authors:  Sukumaran Anil; Mohamed Hashem; Sajith Vellappally; Shankargouda Patil; H M H N Bandara; L P Samaranayake
Journal:  Mycopathologia       Date:  2014-08-21       Impact factor: 2.574

4.  Gentian violet exhibits activity against biofilms formed by oral Candida isolates obtained from HIV-infected patients.

Authors:  Rana S Traboulsi; Pranab K Mukherjee; Jyotsna Chandra; Robert A Salata; Richard Jurevic; Mahmoud A Ghannoum
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

5.  Miconazole mucoadhesive tablet for oropharyngeal candidiasis.

Authors:  Rajesh V Lalla; René-Jean Bensadoun
Journal:  Expert Rev Anti Infect Ther       Date:  2011-01       Impact factor: 5.091

6.  Amino acid-derived 1,2-benzisothiazolinone derivatives as novel small-molecule antifungal inhibitors: identification of potential genetic targets.

Authors:  Deepu Alex; Francoise Gay-Andrieu; Jared May; Linta Thampi; Dengfeng Dou; Aileen Mooney; William Groutas; Richard Calderone
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

Review 7.  Candida dubliniensis: epidemiology and phenotypic methods for identification.

Authors:  Erico Silva Loreto; Liliane A Scheid; Cristina W Nogueira; Gilson Zeni; Janio M Santurio; Sydney H Alves
Journal:  Mycopathologia       Date:  2010-02-21       Impact factor: 2.574

8.  Occurrence of oral Candida colonization and its risk factors among patients with malignancies in China.

Authors:  Haiyan Sun; Yong Chen; Xuan Zou; Huan Li; Xiuyun Yin; Haifeng Qin; Rongrui Liu; Changlin Yu; Qihong Li; Kaitao Yu; Xuelin Han; Jingcai Zou; Cheng Ge; Li Han
Journal:  Clin Oral Investig       Date:  2015-07-30       Impact factor: 3.573

9.  Oral candidiasis in HIV-uninfected pediatric population in areas with limited fungal diagnosis: A case study from a tertiary hospital, Tanzania.

Authors:  Martha F Mushi; Neema Loi; Stephen E Mshana
Journal:  Ther Adv Infect Dis       Date:  2021-05-20

10.  Frequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest Ethiopia.

Authors:  Andargachew Mulu; Afework Kassu; Belay Anagaw; Beyene Moges; Aschalew Gelaw; Martha Alemayehu; Yeshambel Belyhun; Fantahun Biadglegne; Zewdu Hurissa; Feleke Moges; Emiko Isogai
Journal:  BMC Infect Dis       Date:  2013-02-12       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.